Compounds > n(1),n(11)-diethylnorspermine
Page last updated: 2024-10-31

n(1),n(11)-diethylnorspermine and Emesis

n(1),n(11)-diethylnorspermine has been researched along with Emesis in 1 studies

N(1),N(11)-diethylnorspermine: structure given in first source

Research Excerpts

ExcerptRelevanceReference
"Twenty-nine patients were treated with DENSPM using a dosing schedule of once daily for 5 days."2.70Phase I study of N(1),N(11)-diethylnorspermine in patients with non-small cell lung cancer. ( Bowling, K; Casero, RA; Chen, TL; Ettinger, DS; Hahm, HA; Hoker, B; Zabelina, Y, 2002)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hahm, HA1
Ettinger, DS1
Bowling, K1
Hoker, B1
Chen, TL1
Zabelina, Y1
Casero, RA1

Trials

1 trial available for n(1),n(11)-diethylnorspermine and Emesis

ArticleYear
Phase I study of N(1),N(11)-diethylnorspermine in patients with non-small cell lung cancer.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2002, Volume: 8, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Dose-Response

2002